Skip to main content
Log in

Brain-derived neurotrophic factor

Vom Nervenwachstumsfaktor zum Plastizitätsmodulator bei kognitiven Prozessen und psychischen Erkrankungen

Brain-derived neurotrophic factor

From nerve growth factor to modulator of brain plasticity in cognitive processes and psychiatric diseases

  • Übersichten
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Der „brain-derived neurotrophic factor“ (BDNF) gehört zur Familie der Neurotrophine und spielt eine wichtige Rolle beim axonalen und dendritischen Wachstum von Neuronen und der Gehirnplastizität. Die Proform von BDNF (pro-BDNF) wird in den synaptischen Spalt ausgeschüttet und dort durch die Protease Plasmin zum maturen BDNF abgebaut. BDNF fördert die synaptische Plastizität und eine Langzeitpotenzierung. Neuere Untersuchungsergebnisse deuten auf eine Beteiligung von BDNF und dessen genetischer funktioneller Polymorphismen bei der Pathogenese verschiedener psychischer Erkrankungen wie z. B. Depression, Manie, Schizophrenie, Essstörungen, Demenz und Huntington-Erkrankung hin. Die BDNF-Konzentration im Gehirn, aber auch im Serum wird durch verschiedene Faktoren beeinflusst. Sie ist z. B. durch Stress vermindert und wird durch Lernprozesse, verschiedene antidepressive Therapiemodalitäten, körperliche Aktivität und Diät erhöht. Die Bestimmung der BDNF-Serumspiegel könnte diagnostische Bedeutung erlangen. Daneben könnte die gezielte Beeinflussung der BDNF-Verfügbarkeit durch verschiedene Maßnahmen eine Relevanz zur Therapie und möglicherweise auch zur Prävention oben genannter psychischer Krankheitsbilder gewinnen.

Summary

Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family and plays an important role in neuronal survival and plasticity in the CNS. The proform of BDNF (pro-BDNF) is secreted and cleaved extracellularly by the serine protease plasmin to mature BDNF, which potentiates synaptic plasticity and long-term potentiation. Recent findings in animal models suggest an involvement of BDNF and its genetic functional single nucleotide polymorphism in the pathogenesis of different psychiatric diseases including depression, mania, schizophrenia, eating disorders, dementia, and Huntington’s disease. In the brain and serum, BDNF is modulated by different factors. It is downregulated by stress and upregulated by learning processes, several antidepressive treatments, physical activity, and dietary restriction. Measurement of BDNF serum concentrations may be of diagnostic value. Additionally, the influence of different strategies for BDNF allocation seems to be relevant for the treatment and prevention of the above psychiatric disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literaturverzeichnis

  1. Altar CA, Laeng P, Jurata LW et al. (2004) Electroconvulsive seizures regulate gene expression of distinct neurotrophic signalling pathways. J Neurosci 24:2667–2677

    Article  PubMed  Google Scholar 

  2. Altar CA, Whitehead RE, Chen R et al. (2003) Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54:703–709

    Article  PubMed  Google Scholar 

  3. Altar CA (1999) Neurotrophins and depression. Trends Pharmacol Sci 20:59–61

    Article  PubMed  Google Scholar 

  4. Andersen SL, Teicher MH (2004) Delayed effects of early stress on hippocampal development. Neuropsychopharmacology 29:1988–1993

    Article  PubMed  Google Scholar 

  5. Angelucci F, Aloe L, Jimenez-Vasquez P et al. (2002) Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J ECT 18:138–143

    Article  PubMed  Google Scholar 

  6. Angelucci F, Mathe AA, Aloe L (2000) Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J Neurosci Res 60:783–794

    Article  PubMed  Google Scholar 

  7. Angelucci F, Mathe AA, Aloe L (2004) Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res 146:151–165

    PubMed  Google Scholar 

  8. Babyak M, Blumenthal JA, Herman S et al. (2000) Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months. Psychosom Med 62:633–638

    PubMed  Google Scholar 

  9. Bai O, Chlan-Fourney J, Bowen R et al. (2003) Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res 71:127–131

    Article  PubMed  Google Scholar 

  10. Barrientos RM, Sprunger DB, Campeau S et al. (2003) Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 121:847–853

    Article  PubMed  Google Scholar 

  11. Bear MF (2003) Bidirectional synaptic plasticity: from theory to reality. Philos Trans R Soc Lond B Biol Sci 358:649–655

    Article  PubMed  Google Scholar 

  12. Berchtold NC, Kesslak JP, Pike CJ et al. (2001) Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur J Neurosci 14:1992–2002

    Article  PubMed  Google Scholar 

  13. Blasko I, Grubeck-Loebenstein B (2003) Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer’s disease. Drugs Aging 20:101–113

    PubMed  Google Scholar 

  14. Bova R, Micheli MR, Qualadrucci P et al. (1998) BDNF and trkB mRNAs oscillate in rat brain during the light-dark cycle. Brain Res Mol Brain Res 57:321–324

    Article  PubMed  Google Scholar 

  15. Brown GW, Harris TO, Hepworth C (1994) Life events and endogenous depression: a puzzle reexamined. Arch Gen Psychiatry 51:525–534

    PubMed  Google Scholar 

  16. Calabresi P, Napolitano M, Centonze D et al. (2000) Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur J Neurosci 12:1002–1012

    Article  PubMed  Google Scholar 

  17. Cartwright M, Mikheev AM, Heinrich G (1994) Expression of neurotrophin genes in human fibroblasts: differential regulation of the brain-derived neurotrophic factor gene. Int J Dev Neurosci 12:685–693

    Article  PubMed  Google Scholar 

  18. Combarros O, Infante J, Llorca J et al. (2004) Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer’s disease. Dement Geriatr Cogn Disord 18:55–58

    Article  PubMed  Google Scholar 

  19. Coppell AL, Pei Q, Zetterstrom TS (2003) Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropsychopharmacology 44:903–910

    Article  Google Scholar 

  20. Duman RS (1998) Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 44:324–335

    Article  PubMed  Google Scholar 

  21. Egan MF, Kojima M, Callicott JH et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257–269

    Article  PubMed  Google Scholar 

  22. Erickson JT, Conover JC, Borday V et al. (1996) Mice lacking brain-derived neurotrophic factor exhibit visceral sensory neuron losses distinct from mice lacking NT4 and display a severe developmental deficit in control of breathing. J Neurosci 16:5361–5371

    PubMed  Google Scholar 

  23. Ernfors P, Lee KF, Jaenisch R (1994) Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368:147–150

    Article  PubMed  Google Scholar 

  24. Eriksson PS, Perfilieva E, Bjork-Eriksson T et al. (1998) Neurogenesis in the adult human hippocampus. Nat Med 4:1313–1317

    Article  PubMed  Google Scholar 

  25. Eschweiler GW (2003) Modelle zum Wirkmechanismus der Elektrokrampftherapie. In: Eschweiler GW, Wild B, Bartels M (Hrsg) Elektromagnetische Therapien in der Psychiatrie. Steinkopff, Darmstadt, S 92ff

  26. Fahnestock M, Garzon D, Holsinger RM et al. (2002) Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule? J Neural Transm Suppl 62:241–252

    PubMed  Google Scholar 

  27. Fox EA, Byerly MS (2004) A mechanism underlying mature-onset obesity: evidence from the hyperphagic phenotype of brain-derived neurotrophic factor mutants. Am J Physiol Regul Integr Comp Physiol 286:994–1004

    Google Scholar 

  28. Fumagalli F, Bedogni F, Perez J et al. (2004) Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neurosci 20:1348

    Article  PubMed  Google Scholar 

  29. Garcia R (2002) Stress, metaplasticity, and antidepressants. Curr Mol Med 2:629–638

    Article  PubMed  Google Scholar 

  30. Gauthier LR, Charrin BC, Borrell-Pages M et al. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127–138

    Article  PubMed  Google Scholar 

  31. Gold SM, Schulz KH, Hartmann S et al. (2003) Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls. J Neuroimmunol 138:99–105

    Article  PubMed  Google Scholar 

  32. Grimm JW, Lu L, Hayashi T et al. (2003) Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 23:742–747

    PubMed  Google Scholar 

  33. Hairston IS, Peyron C, Denning DP et al. (2003) Sleep deprivation effects on growth factor expression in neonatal rats: a potential role for BDNF in the mediation of delta power. J Neurophysiol 91:1586–1595

    Article  PubMed  Google Scholar 

  34. Hall FS, Drgonova J, Goeb M et al. (2003) Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 28:1485–1490

    Article  PubMed  Google Scholar 

  35. Hall D, Dhilla A, Charalambous A et al. (2003) Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 73:370–376

    Article  PubMed  Google Scholar 

  36. Hampton KK, Grant PJ, Boothby M et al. (1990) The effect of modified electroconvulsive therapy on vasopressin release and haemostasis in man. Blood Coagul Fibrinolysis 1:293–297

    PubMed  Google Scholar 

  37. Hollmann W, Strüder HK, Tangarakis CVM (2003) Körperliche Aktivität fördert Gehirngesundheit und -leistungsfähigkeit. Übersicht und eigene Befunde. Nervenheilkunde 22:467–474

    Google Scholar 

  38. Horger BA, Iyasere CA, Berhow MT et al. (1999) Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 19:4110–4122

    PubMed  Google Scholar 

  39. Karege F, Perret G, Bondolfi G et al. (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143–148

    Article  PubMed  Google Scholar 

  40. Karege F, Schwald M, Cisse M (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328:261–264

    Article  PubMed  Google Scholar 

  41. Kipnis J, Cohen H, Cardon M et al. (2004) T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci USA 101:8180–8185

    Article  PubMed  Google Scholar 

  42. Koizumi H, Hashimoto K, Itoh K et al. (2004) Association between the brain-derived neurotrophic factor 196G/A polymorphism and eating disorders. Am J Med Genet 127:125–127

    Article  Google Scholar 

  43. Koprich JB, Campbell NG, Lipton JW (2003) Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat. Brain Res Dev Brain Res 147:177–182

    Article  PubMed  Google Scholar 

  44. Kunigi H, Ueki A, Otsuka M et al. (2001) A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer’s disease. Mol Psychiatry 6:83–86

    Article  PubMed  Google Scholar 

  45. Kunugi H, Iijima Y, Tatsumi M et al. (2004) No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol Psychiatry 56:376–378

    Article  PubMed  Google Scholar 

  46. Lang UE, Hellweg R, Gallinat J (2004) BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 29:795–798

    Article  PubMed  Google Scholar 

  47. Laske C, Stransky E, Eschweiler G et al. (2005) BDNF serum concentrations in patients with Alzheimer’s disease are associated with depressive mood states. Neurol Psychiatr Brain Res 12:1–4

    Google Scholar 

  48. Laske C, Stransky E, Eschweiler GW et al. (2005) Correlation of BDNF and IL-6 serum concentrations in Alzheimer’s disease. Neurol Psychiatr Brain Res 12:21–24

    Google Scholar 

  49. Laske C, Morawetz C, Buchkremer G et al. (2005) Präventive Maßnahmen bei demenziellen Erkrankungen. Dtsch Ärztebl 102:A1446–1453

    Google Scholar 

  50. Laske C, Stransky E, Eschweiler GW et al. (2005) Brain-derived neurotrophic factor (BDNF) in serum of patients with mania, major depression and healthy controls. Neurol Psychiatr Brain Res 12:25–28

    Google Scholar 

  51. Lee R, Kermani P, Teng KK et al. (2001) Regulation of cell survival by secreted proneurotrophins. Science 294:1945–1948

    Article  PubMed  Google Scholar 

  52. Leibrock J, Lottspeich F, Hohn A et al. (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341:149–152

    Article  PubMed  Google Scholar 

  53. Leriche L, Diaz J, Sokoloff P (2004) BDNF bridges the gap between NMDA receptor blockade and schizophrenia-related abnormalities. FENS Forum Abstracts A232.1 (2)

  54. Lever I, Cunningham J, Grist J et al. (2003) Release of BDNF and GABA in the dorsal horn of neuropathic rats. Eur J Neurosci 18:1169–1174

    Article  PubMed  Google Scholar 

  55. Lommatzsch M, Braun A, Mannsfeldt A et al. (1999) Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol 155:1183–1193

    PubMed  Google Scholar 

  56. Lu B (2003) BDNF and activity-dependent synaptic modulation. Learn Mem 10:86–98

    Article  PubMed  Google Scholar 

  57. Lu L, Dempsey J, Liu SY et al. (2004) A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 24:1604–1611

    Article  PubMed  Google Scholar 

  58. Lu B, Gottschalk W (2000) Modulation of hippocampal synaptic transmission and plasticity by neurotrophins. Prog Brain Res 128:231–241

    PubMed  Google Scholar 

  59. MacQueen GM, Ramakrishnan K, Croll SD et al. (2001) Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 115:1145–1153

    Article  PubMed  Google Scholar 

  60. Malberg JE, Eisch AJ, Nestler EJ et al. (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104–9110

    PubMed  Google Scholar 

  61. Malcangio M, Lessmann V (2003) A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. Trends Pharmacol Sci 24:116–121

    Article  PubMed  Google Scholar 

  62. Martin-Iverson MT, Altar CA (1996) Spontaneous behaviours of rats are differentially affected by substantia nigra infusions of brain-derived neurotrophic factor and neurotrophin-3. Eur J Neurosci 8:1696–1706

    PubMed  Google Scholar 

  63. Mattson MP, Duan W, Wan W et al. (2004) Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations. NeuroRx 1:111–116

    Article  PubMed  Google Scholar 

  64. Molnar M, Potkin SG, Bunney WE et al. (2003) MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients. Biol Psychiatry 53:39–47

    Article  PubMed  Google Scholar 

  65. Mowla SJ, Farhadi HF, Pareek S et al. (2001) Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 276:12660–12666

    Article  PubMed  Google Scholar 

  66. Mowla SJ, Pareek S, Farhadi HF et al. (1999) Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J Neurosci 19:2069–2080

    PubMed  Google Scholar 

  67. Müller MB, Toschi N, Kresse AE et al. (2000) Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology 23:205–215

    Article  PubMed  Google Scholar 

  68. Nakazato M, Hashimoto K, Shimizu C et al. (2003) Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 54:485–490

    Article  PubMed  Google Scholar 

  69. Narita M, Aoki K, Takagi M et al. (2003) Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 119:767–775

    Article  PubMed  Google Scholar 

  70. Neves-Pereira M, Mundo E, Muglia P et al.(2002) The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71:651–655

    Article  PubMed  Google Scholar 

  71. Nibuya M, Morinobu S, Duman RS (1995) J Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539–7547

    PubMed  Google Scholar 

  72. Nishimura AL, Oliveira JR, Mitne-Neto M et al. (2004) Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer’s disease (LOAD) in Brazilian patients. J Mol Neurosci 22:257–260

    Article  PubMed  Google Scholar 

  73. Nosrat IV, Lindskog S, Seiger A et al. (2000) Lingual BDNF and NT-3 mRNA expression patterns and their relation to innervation in the human tongue: similarities and differences compared with rodents. J Comp Neurol 417:133–152

    Article  PubMed  Google Scholar 

  74. O’Leary PD, Hughes RA (2003) Design of potent peptide mimetics of brain-derived neurotrophic factor. J Biol Chem 278:25738–25744

    Article  PubMed  Google Scholar 

  75. Oswald P, Del-Favero J, Massat I et al. (2004) Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study. Am J Med Genet 129:34–35

    Article  Google Scholar 

  76. Pan W, Banks WA, Fasold MB et al. (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:1553–1561

    Article  PubMed  Google Scholar 

  77. Pang PT, Teng HK, Zaitsev E et al. (2004) Cleavage of pro-BDNF by tPA/Plasmin is essential for long-term hippocampal plasticity. Science 306:487–491

    Article  PubMed  Google Scholar 

  78. Pawlak R, Nagai N, Urano T et al. (2004) Rapid, specific and active site-catalyzed effect of tissue-plasminogen activator on hippocampus-dependent learning in mice. Neuroscience 113:995–1001

    Article  Google Scholar 

  79. Pezawas L, Verchinski BA, Mattay VS et al. (2004) The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24:10099–10102

    Article  PubMed  Google Scholar 

  80. Phillips HS, Hains JM, Armanini M et al. (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 7:695–702

    Article  PubMed  Google Scholar 

  81. Pirildar S, Gonul AS, Taneli F et al. (2004) Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Prog Neuropsychopharmacol Biol Psychiatry 28:709–713

    Article  PubMed  Google Scholar 

  82. Poduslo JF, Curran GL (1996) Permeability at the blood-brain barrier and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Mol Brain Res 36:280–286

    Article  PubMed  Google Scholar 

  83. Poo MM (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci 2:24–32

    Article  PubMed  Google Scholar 

  84. Rajkowska G (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48:766–777

    Article  PubMed  Google Scholar 

  85. Ribases M, Gratacos M, Armengol L et al. (2003) Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry 8:745–751

    Article  PubMed  Google Scholar 

  86. Ribases M, Gratacos M, Fernandez-Aranda F et al. (2004) Association of BDNF with anorexia, bulimia and age onset of weight loss in six European populations. Hum Mol Genet 13:1205–1212

    Article  PubMed  Google Scholar 

  87. Riemenschneider M, Schwarz S, Wagenpfeil S et al. (2002) A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer’s disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol Psychiatry 7:782–785

    Article  PubMed  Google Scholar 

  88. Roceri M, Hendriks W, Racagni G et al. (2002) Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Mol Psychiatry 7:609–616

    Article  PubMed  Google Scholar 

  89. Roceri M, Cirulli F, Pessina C et al. (2004) Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol Psychiatry 55:708–714

    Article  PubMed  Google Scholar 

  90. Rybakowski JK, Borkowska A, Czerski PM et al. (2003) Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 5:468–472

    Article  PubMed  Google Scholar 

  91. Santarelli L, Saxe M, Gross C et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805–809

    Article  PubMed  Google Scholar 

  92. Scaccianoce S, Del Bianco P, Caricasole A et al. (2003) Relationship between learning, stress and hippocampal brain-derived neurotrophic factor. Neuroscience 121:825–828

    Article  PubMed  Google Scholar 

  93. Schaaf MJ, De Kloet ER, Vreugdenhil E (2000) Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress 3:201–208

    PubMed  Google Scholar 

  94. Sheline YI, Gado MH, Kraemer HC (2003) Untreated depression and hippocampal volume loss. Am J Psychiatry 160:1516–1518

    Article  PubMed  Google Scholar 

  95. Shimizu E, Hashimoto K, Okamura N et al. (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70–75

    Article  PubMed  Google Scholar 

  96. Shimizu E, Hashimoto K, Watanabe H et al. (2003) Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett 351:111–114

    Article  PubMed  Google Scholar 

  97. Singh M, Meyer EM, Simpkins JW (1995) The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136:2320–2324

    Article  PubMed  Google Scholar 

  98. Singh NA, Clements KM, Singh MAF (2001) The efficacy of exercise as a long-term antidepressant in elderly subjects: a randomised, controlled trial. J Gerontology 56:497–504

    Google Scholar 

  99. Siuciak JA, Lewis DR, Wiegand SJ et al. (1997) Antidepressive-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56:131–137

    Article  PubMed  Google Scholar 

  100. Siuciak JA, Altar CA, Wiegand SJ et al. (1994) Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Res 633:326–330

    Article  PubMed  Google Scholar 

  101. Sklar P, Gabriel SB, McInnis MG et al. (2002) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 7:579–593

    Article  PubMed  Google Scholar 

  102. Snider WD (1994) Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627–638

    Article  PubMed  Google Scholar 

  103. Stewart C, Reid I (1993) Electroconvulsive stimulation and synaptic plasticity. Brain Res 620:139–141

    Article  PubMed  Google Scholar 

  104. Szekeres G, Juhasz A, Rimanoczy A et al. (2003) The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia. Schizophr Res 65:15–18

    Article  PubMed  Google Scholar 

  105. Tang Y, Yamada K, Kanou Y et al. (2000) Spatiotemporal expression of BDNF in the hippocampus induced by the continuous intracerebroventricular infusion of beta-amyloid in rats. Brain Res Mol Brain Res 80:188–197

    Article  PubMed  Google Scholar 

  106. Thome J, Duman RS, Henn FA (2002) Molecular aspects of antidepressive therapy. Transsynaptic effects on signal transduction, gene expression and neuronal plasticity. Nervenarzt 73:595–599

    Article  PubMed  Google Scholar 

  107. Toyooka K, Asama K, Watanabe Y et al. (2002) Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 110:249–257

    Article  PubMed  Google Scholar 

  108. Tsai SJ, Cheng CY, Yu YW et al. (2003) Association study of a brain-derived neurotrophic factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet 123:19–22

    Article  Google Scholar 

  109. Ventriglia M, Bocchio Chiavetto L, Benussi L et al. (2002) Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer’s disease. Mol Psychiatry 7:136–137

    Article  PubMed  Google Scholar 

  110. Webster MJ, Weickert CS, Herman MM et al. (2002) BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Res Dev Brain Res 139:139–150

    Article  PubMed  Google Scholar 

  111. Weickert CS, Hyde TM, Lipska BK et al. (2003) Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8:592–610

    Article  PubMed  Google Scholar 

  112. Xu B, Goulding EH, Zang K et al. (2003) Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6:736–742

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Laske.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laske, C., Eschweiler, G.W. Brain-derived neurotrophic factor. Nervenarzt 77, 523–537 (2006). https://doi.org/10.1007/s00115-005-1971-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-005-1971-0

Schlüsselwörter

Keywords

Navigation